2020
DOI: 10.1016/j.ajp.2019.101876
|View full text |Cite
|
Sign up to set email alerts
|

Change in prevalence of metabolic syndrome in patients with bipolar disorder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 17 publications
1
9
0
Order By: Relevance
“…In accordance with previous studies, we found that MetS cases were higher in the bipolar group (30%) than in the control group (15%; Garcia-Portilla et al, 2008 ; Babić et al, 2010 ; Salvi et al, 2011 ; Grover et al, 2012 , 2020 ; Czepielewski et al, 2013 ; Vancampfort et al, 2015 ; Almasabi et al, 2020 ). In HC, the prevalence was lower than in an Austrian comparative group ( Wascher, 2002 ), possibly caused by younger age and higher educational level in the control group.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…In accordance with previous studies, we found that MetS cases were higher in the bipolar group (30%) than in the control group (15%; Garcia-Portilla et al, 2008 ; Babić et al, 2010 ; Salvi et al, 2011 ; Grover et al, 2012 , 2020 ; Czepielewski et al, 2013 ; Vancampfort et al, 2015 ; Almasabi et al, 2020 ). In HC, the prevalence was lower than in an Austrian comparative group ( Wascher, 2002 ), possibly caused by younger age and higher educational level in the control group.…”
Section: Discussionsupporting
confidence: 92%
“…Nevertheless, most studies agree that the prevalence of MetS is significantly higher in individuals with BD than in healthy controls (HC; Czepielewski et al, 2013;Vancampfort et al, 2016;Almasabi et al, 2020), with an odds ratio (OR) as high as 2.94 (95% CI, 2. 08-4.17;Almasabi et al, 2020) and that there is an increase in the MetS prevalence among patients with BD in the longitudinal course (Almasabi et al, 2020;Grover et al, 2020). Multiple factors that contribute to these high rates exist, among them psychopharmaceutical effects, inflammatory processes, and unhealthy lifestyle including poor diet and exercise habits (Gurpegui et al, 2012;Swartz and Fagiolini, 2012;Geddes and Miklowitz, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…Bipolar disorder is often accompanied by elevated blood lipid, abnormal glucose metabolism, obesity or elevated blood pressure; and even a considerable proportion of patients have MetS, which has been confirmed in many clinical studies. The prevalence of comorbidity with MetS in bipolar patients is very high, it may be related to special biology, lifestyle, and atypical antipsychotics [26]. This also suggests that MetS is indeed a problem in patients with bipolar disorder.…”
Section: Discussionmentioning
confidence: 99%
“…Different degrees of dyslipidemia, such as increased triglycerides (TG) ( 20 ), increased cholesterol (CHOL), low-density lipoprotein cholesterol (LDL-C) ( 21 ), or decreased high-density lipoprotein cholesterol (HDL-C) ( 22 ) are common in patients with BD. A decrease in HDL-C affects the central nervous system (CNS) and is a risk factor for BD patients ( 23 ).…”
Section: Introductionmentioning
confidence: 99%